New tools for functional mammalian cancer genetics

Nature Reviews Cancer

Volumn 3, Issue 10, 2003, Pages 781-789

  Brummelkamp, Thijn R ^a   Bernards, René ^a  

^a NETHERLANDS CANCER INSTITUTE   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

BETA CATENIN; COMPLEMENTARY DNA; CYTOSTATIC AGENT; DEATH ASSOCIATED PROTEIN KINASE; DNA; DNA FRAGMENT; DOUBLE STRANDED RNA; G PROTEIN COUPLED RECEPTOR; GENE PRODUCT; IMATINIB; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MIGRATION INHIBITION FACTOR; PROTEIN BCL 6; PROTEIN FANCONI ANEMIA GROUP C; RIBOZYME; RNA; TRANSCRIPTION FACTOR TWIST; UNCLASSIFIED DRUG; VIRUS VECTOR;

CELL INTERACTION; DNA HYBRIDIZATION; DNA ISOLATION; DNA LIBRARY; DNA MICROARRAY; GENE AMPLIFICATION; GENE DELIVERY SYSTEM; GENE FUNCTION; GENE IDENTIFICATION; GENE INTERACTION; GENE LIBRARY; GENETIC CODE; GENETIC TRANSFECTION; GROWTH REGULATION; MOLONEY LEUKEMIA ONCOVIRUS; MULTIGENE FAMILY; NONHUMAN; ONCOGENE; ONCOGENE H RAS; PRIORITY JOURNAL; REVIEW; RNA INTERFERENCE; SIGNAL TRANSDUCTION; TUMOR GROWTH; VIRAL GENE DELIVERY SYSTEM; ANIMAL; GENETIC PROCEDURES; GENETICS; HUMAN; MAMMAL; NEOPLASM; PHYSIOLOGY;

ANIMALS; GENETIC TECHNIQUES; HUMANS; MAMMALS; NEOPLASMS;

EID: 0142259345     PISSN: 1474175X     EISSN: None     Source Type: Journal    
DOI: 10.1038/nrc1191     Document Type: Review

References (73)

1. Hanahan, D. & Weinberg, R. A. The hallmarks of cancer. Cell 100, 57-70 (2000).
2. Sherr, C. J. & DePinho, R. A. Cellular senescence: mitotic clock or culture shock? Cell 102, 407-410 (2000).
3. Lin, S. Y. & Elledge, S. J. Multiple tumor suppressor pathways negatively regulate telomerase. Cell 113, 881-889 (2003).
4. Graham, F. L. & van der Eb, A. J. A new technique for the assay of infectivity of human adenovirus 5 DNA. Virology 52, 456-467 (1973).
5. Graham, F. L., van der Eb, A. J. & Heijneker, H. L. Size and location of the transforming region in human adenovirus type 5 DNA. Nature 251, 687-891 (1974).
6. Shih, C. & Weinberg, R. A. Isolation of a transforming sequence from a human bladder carcinoma cell line. Cell 29, 161-169 (1982).
7. Goldfarb, M., Shimizu, K., Perucho, M. & Wigler, M. Isolation and preliminary characterization of a human transforming gene from T24 bladder carcinoma cells. Nature 296, 404-409 (1982).
8. Belt, P. B. et al. Efficient cDNA cloning by direct phenotypic correction of a mutant human cell line (HPRT-) using an Epstein-Barr virus-derived cDNA expression vector. Nucl. Acids Res. 19, 4861-4866 (1991).
9. Strathdee, C. A., Gavish, H., Shannon, W. R. & Buchwald, M. Cloning of cDNAs for Fanconi's anaemia by functional complementation. Nature 356, 763-767 (1992).
10. Lo Ten Foe, J. R. et al. Expression cloning of a cDNA for the major Fanconi anaemia gene, FAA. Nature Genet. 14, 320-323 (1996).
11. de Winter, J. P. et al. The Fanconi anaemia group G gene FANCG is identical with XRCC9. Nature Genet. 20, 281-283 (1998).
12. de Winter, J. P. et al. The Fanconi anaemia gene FANCF encodes a novel protein with homology to ROM. Nature Genet. 24, 15-16 (2000).
13. Pear, W. S., Nolan, G. P., Scott, M. L. & Baltimore, D. Production of high-titer helper-free retroviruses by transient transfection. Proc. Natl Acad. Sci. USA 90, 8392-8396 (1993).
14. Kitamura, T. et al. Efficient screening of retroviral cDNA expression libraries. Proc. Natl Acad. Sci. USA 92, 9146-9150 (1995).
15. Zannettino, A. C., Rayner, J. R., Ashman, L. K., Gonda, T. J. & Simmons, P. J. A powerful new technique for isolating genes encoding cell surface antigens using retroviral expression cloning. J. Immunol. 156, 611-820 (1996).
16. Whitehead, I., Kirk, H. & Kay, R. Expression cloning of oncogenes by retroviral transfer of CDNA libraries. Mol. Cell Biol. 15, 704-710 (1995).
17. Shvarts, A. et al. A senescence rescue screen identifies BCL6 as an inhibitor of anti-proliferative p19(ARF)-p53 signaling Genes Dev. 16, 681-686 (2002).
18. Berns, K., Hijmans, E. M., Koh, E., Daley, G. Q. & Bernards, R. A genetic screen to identify genes that rescue the slow growth phenotype of c-myc null fibroblasts. Oncogene 19, 3330-3334 (2000).
19. Hitoshi, Y. et al. Toso, a cell surface, specific regulator of Fas-induced apoptosis in T cells Immunity 8, 461-471 (1998).
20. Lewis, P. F. & Emerman, M. Passage through mitosis is required for oncoretroviruses but not for the human immunodeficiency virus. J. Virol. 68, 510-516 (1994).
21. Michiels, F. et al. Arrayed adenoviral expression libraries for functional screening. Nature Biotechnol. 20, 1154-1157 (2002).
22. Ziauddin, J. & Sabatini, D. M. Microarrays of cells expressing defined cDNAs. Nature 411, 107-110 (2001).
23. Gudkov, A. V. et al. Cloning mammalian genes by expression selection of genetic suppressor elements: association of kinesin with drug resistance and cell immortalization. Proc. Natl Acad. Sci. USA 91, 3744-3748 (1994).
24. Levenson, V. V. et al. A combination of genetic suppressor elements produces resistance to drugs inhibiting DNA replication. Somat. Cell Mol. Genet. 25, 9-26 (1999).
25. Novoa, I., Zeng, H., Harding, H. P. & Ron, D. Feedback inhibition of the unfolded protein response by GADD34-mediated dephosphorylation of elF2α. J. Cell Biol. 153, 1011-1022 (2001).
26. Garkavtsev, I., Kazarov, A., Gudkov, A. & Riabowol, K. Suppression of the novel growth inhibitor p33ING1 promotes neoplastic transformation. Nature Genet. 14, 415-420 (1996).
27. Kimchi, A. Antisense libraries to isolate tumor suppressor genes. Methods Mol. Biol. 222, 399-412 (2003).
28. Deiss, L. P. & Kimchi, A. A genetic tool used to identify thioredoxin as a mediator of a growth inhibitory signal. Science 252, 117-120 (1991).
29. Cohen, O. Kimchi, A. DAP-kinase: from functional gene cloning to establishment of its role in apoptosis and cancer. Cell Death Differ. 8, 6-15 (2001).
30. Deiss, L. P., Feinstein, E., Berissi, H., Cohen, O. & Kimchi, A. Identification of a novel serine/threonine kinase and a novel 15-kD protein as potential mediators of they interferon-induced cell death. Genes Dev. 9, 15-30 (1995).
31. Beger, C. et al. Identification of Id4 as a regulator of BRCA1 expression by using a ribozyme-library-based inverse genomics approach. Proc. Natl Acad. Sci. USA 98, 130-135 (2001).
32. Welch, P. J. et al. Identification and validation of a gene involved in anchorage-independent cell growth control using a library of randomized hairpin ribozymes. Genomics 66, 274-283 (2000).
33. Kawasaki, H. et al. Distinct roles of the co-activators p300 and CBP in retinoic-acid-induced F9-cell differentiation. Nature 393, 284-289 (1998).
34. Cobs, P. et al. Genetic selection of peptide aptamers that recognize and inhibit cyclin-dependent kinase 2. Nature 380, 548-550 (1996).
35. Xu, X. et al. Dominant effector genetics in mammalian cells Nature Genet. 27, 23-29 (2001).
36. Jorgensen, E. M. & Mango, S. E. The art and design of genetic screens: Caenorhabditis elegans. Nature Rev. Genet. 3, 356-369 (2002).
37. Fire, A. et al. Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans. Nature 391, 806-811 (1998).
38. Plasterk, R. H. RNA silencing: the genome's immune system. Science 296, 1263-1265 (2002).
39. Hannon, G. J. RNA interference. Nature 418, 244-251 (2002)
40. Fraser, A. G. et al. Functional genomic analysis of C. elegans chromosome I by systematic RNA interference. Nature 408, 325-330 (2000).
41. Kamath, R. S. et al. Systematic functional analysis of the Caenorhabditis elegans genome using RNAi. Nature 421, 231-237 (2003).
42. Ashrafi, K. et al. Genome-wide RNAi analysis of Caenorhabditis elegans fat regulatory genes. Nature 421, 268-272 (2003)
43. Pothof, J. et al. Identification of genes that protect the C. elegans genome against mutations by genome-wide RNAi. Genes Dev. 17, 443-448 (2003).
44. Lum, L. et al. Identification of Hedgehog pathway components by RNAi in Drosophila cultured cells. Science 299, 2039-2045 (2003).
45. Elbashir, S. M. et al. Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells. Nature 411, 494-498 (2001).
46. Brummelkamp, T. R., Bemards, R. & Agami, R. A system for stable expression of short interfering RNAs in mammalian cells. Science 296, 550-553 (2002).
47. Paddison, P. J., Caudy, A. A., Bemstein, E., Hannon, G. J. & Conklin, D. S. Short hairpin RNAs (shRNAs) induce sequence-specific silencing in mammalian cells. Genes Dev. 16, 948-958 (2002).
48. Paul, C. P., Good, P. D., Winer, I. & Engelke, D. R. Effective expression of small interfering RNA in human cells. Nature Biotechnol. 20, 505-508 (2002).
49. Miyagishi, M. & Taira, K. U6 promoter-driven siRNAs with four uridine 3′ overhangs efficiently suppress targeted gene expression in mammalian cells. Nature Biotechnol. 20, 497-500 (2002).
50. Lee, N. S. et al. Expression of small interfering RNAs targeted against HIV-1 rev transcripts in human cells. Nature Biotechnol. 20, 500-505 (2002).
51. Paddison, P. J. & Hannon, G. J. RNA interference: the new somatic cell genetics? Cancer Cell 2, 17-23 (2002).
52. Brummelkamp, T. R., Bemards, P. & Agami, R. Stable suppression of tumorigenicity by virus-mediated RNA interference. Cancer Cell 2, 243-247 (2002).
53. Dirac, A. M. & Bemards, R. Reversal of senescence in mouse fibroblasts through lentiviral suppression of p53. J. Biol. Chem. 278, 11731-11734 (2003).
54. Abbas-Terki, T., Blanco-Bose, W., Deglon, N., Pralong, W. & Aebischer, P. Lentiviral-mediated RNA interference. Hum. Gene Ther. 13, 2197-2201 (2002).
55. Rubinson, D. A. et al. A lentivirus-based system to functionally silence genes in primary mammalian cells, stem cells and transgenic mice by RNA interference. Nature Genet. 33, 401-406 (2003).
56. Scherr, M., Battmer, K., Ganser, A. & Eder, M. Modulation of gene expression by lentiviral-mediated delivery of small interfering RNA. Cell Cycle 2, 251-257 (2003).
57. Qin, X. F., An, D. S., Chen, I. S. & Baltimore, D. Inhibiting HIV-1 infection in human T cells by lentiviral-mediated delivery of small interfering RNA against CCR5. Proc. Natl Acad. Sci. USA 100, 183-188 (2003).
58. McCaffrey, A. P. et al. RNA interference in adult mice. Nature 418, 38-39 (2002).
59. Kunath, T. et al. Transgenic RNA interference in ES cell-derived embryos recapitulates a genetic null phenotype. Nature Biotechnol. 21, 559-561 (2003).
60. Jackson, A. L. et al. Expression profiling reveals off-target gene regulation by RNAi. Nature Biotechnol. 21, 635-637 (2003).
61. Semizarov, D. et al. Specificity of short interfering RNA determined through gene expression signatures. Proc. Natl Acad. Sci. USA 100, 6347-6352 (2003).
62. Chi, J. T. et al. Genomewide view of gene silencing by small interfering RNAs. Proc. Natl Acad. Sci. USA 100, 6343-6346 (2003).
63. Bridge, A. J., Pebernard, S., Ducraux, A., Nicoulaz, A. L. & Iggo, R. Induction of an interferon response by RNAi vectors in mammalian cells. Nature Genet. 34, 263-264 (2003).
64. Brummelkamp, T. R., Niiman, S. M. B., Dirac, A. M. G. & Bernards, R. Loss of the cylindromatosis tumour suppressor inhibits apoptosis by activating NF-κB Nature 424, 797-801 (2003).
65. Shoemaker, D. D., Lashkari, D. A., Morris, D., Mittmann, M. & Davis, R. W. Quantitative phenotypic analysis of yeast deletion mutants using a highly parallel molecular bar-coding strategy. Nature Genet. 14, 450-456 (1996).
66. Winzeler, E. A. et al. Functional characterization of the S. cerevisiae genome by gene deletion and parallel analysis. Science 285, 901-906 (1999).
67. Glaever, G. et al. Functional profiling of the Saccharomyces cerevisiae genome. Nature 418, 387-391 (2002).
68. Hannon, G. J. et al. MARX: an approach to genetics in mammalian cells. Science 283, 1129-1130 (1999).
69. Koh, E. Y., Chen, T. & Daley, G. Q. Novel retroviral vectors to facilitate expression screens in mammalian cells. Nucl. Acids Res. 30, e142 (2002).
70. Hua, X., Liu, X., Ansari, D. O. & Lodish, H. F. Synergistic cooperation of TFE3 and smad proteins in TGF-β-induced transcription of the plasminogen activator inhibitor-1 gene. Genes Dev. 12, 3084-3095 (1998).
71. Hudson, J. D. et al. A proinflammatory cytokine inhibits p53 tumor suppressor activity. J. Exp. Med. 190, 1375-1382 (1999).
72. Maestro, R. et al. Twist is a potential oncogene that inhibits apoptosis. Genes Dev. 13, 2207-2217 (1999).
73. Yamaoka, S. et al. Complementation cloning of NEMO, a component of the IκB kinase complex essential for NF-κB activation. Cell 93, 1231-1240 (1998).